RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John S. Cooperwood to Drug Design

This is a "connection" page, showing publications John S. Cooperwood has written about Drug Design.
Connection Strength

0.336
  1. Musa MA, Khan MO, Cooperwood JS. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs). Curr Med Chem. 2007; 14(11):1249-61.
    View in: PubMed
    Score: 0.273
  2. Lee HJ, Cooperwood JS, You Z, Ko DH. Prodrug and antedrug: two diametrical approaches in designing safer drugs. Arch Pharm Res. 2002 Apr; 25(2):111-36.
    View in: PubMed
    Score: 0.049
  3. Park KK, Ko DH, You Z, Cooperwood JS, Park J, Lee HJ. Chirality effect of C-20 on metabolism of methyl 11beta,17alpha,20-trihydroxy-3-oxo-1,4-pregnadien-21-oate derivatives. Steroids. 2004 Feb; 69(2):87-91.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support